Managing Automation :: Technology Solutions for Progressive Manufacturers Sign in or register  |  Advertise |  Subscribe to MA Magazine  | Newsletters |   My Profile
ManagingAutomation.com Web Exclusive

Editorial insights exclusive to ManagingAutomation.com

Heparin Saga Takes Ominous Turn

Posted on Thursday, May 01, 2008 4:22:34 PM                                  Digg This Article   Add to Delicious

Abstract:Congressional hearings this week reveal the theory that the contamination that killed 81 heparin recipients was a deliberate act of sabotage.

The ongoing saga of heparin contamination, which claimed the lives of 81 people and caused health complications for many others, took an ominous turn this week as word came of a deliberate effort to poison the blood-thinning medication.

As loved ones of the victims and officials from heparin's maker Baxter International testified before Congress this week, the focus shifted from possible cost-cutting shortcuts by the Chinese maker of heparin's ingredients to the more sinister possibility that the addition of the deadly contaminants was a malicious act.

A New York Times article on the hearing quotes David G. Strunce, CEO of Scientific Protein Laboratories, a partner company that supplied heparin material to Baxter International, as saying the product tainting was "an insidious act" that "seems to us an intentional act upstream in the supply chain."

[Click to continue]